Literature DB >> 2522852

Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy.

E R Mathiesen1, E Nexø, E Hommel, H H Parving.   

Abstract

To study the relationship between glomerular and tubular function we investigated glomerular filtration rate (GFR), urinary albumin excretion, and urinary excretion of epidermal growth factor (EGF, a mitogenic peptide synthesized in the renal tubular cells) in normal subjects (group I, n = 7) and in Type 1 (insulin-dependent) diabetic patients with normoalbuminuria (group II, n = 11); with incipient nephropathy (microalbuminuria) (group III, n = 9); with nephropathy and normal GFR (group IV, n = 12); and with reduced GFR (group V, n = 8). EGF (nmol 24 h-1) decreased with progressive glomerular involvement, from 7.9 (4.1-10.5) (median and range) in group I, to 6.7 (1.3-9.2) in group II, 5.0 (3.6-7.4) in group III, 4.1 (2.5-9.5) in group IV, and 1.1 (0.1-2.5) in group V. The urinary excretion of EGF was significantly reduced in patients with elevated UAE (group III, IV, and V) compared with normal control subjects (p less than 0.05). A significant correlation between urinary excretion of EGF and GFR (r = 0.71, p less than 0.001) and an inverse correlation between the urinary excretion of EGF and albumin (r = -0.35, p less than 0.05) was demonstrated in the Type 1 diabetic patients with GFR greater than 90 ml min-1. Our study demonstrates that urinary excretion of epidermal growth factor diminishes with increasing nephron impairment, and that renal tubular function as judged by the excretion of EGF is reduced early in the development of diabetic kidney disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522852     DOI: 10.1111/j.1464-5491.1989.tb02098.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy.

Authors:  Zhi Su; Deborah Widomski; Ji Ma; Marian Namovic; Arthur Nikkel; Laura Leys; Lauren Olson; Katherine Salte; Diana Donnelly-Roberts; Timothy Esbenshade; Steve McGaraughty
Journal:  Am J Nephrol       Date:  2016-10-14       Impact factor: 3.754

2.  Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis.

Authors:  Heather N Reich; Carol Landolt-Marticorena; Paul C Boutros; Rohan John; Joan Wither; Paul R Fortin; Stuart Yang; James W Scholey; Andrew M Herzenberg
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

3.  Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.

Authors:  Wenjun Ju; Viji Nair; Shahaan Smith; Li Zhu; Kerby Shedden; Peter X K Song; Laura H Mariani; Felix H Eichinger; Celine C Berthier; Ann Randolph; Jennifer Yi-Chun Lai; Yan Zhou; Jennifer J Hawkins; Markus Bitzer; Matthew G Sampson; Martina Thier; Corinne Solier; Gonzalo C Duran-Pacheco; Guillemette Duchateau-Nguyen; Laurent Essioux; Brigitte Schott; Ivan Formentini; Maria C Magnone; Maria Bobadilla; Clemens D Cohen; Serena M Bagnasco; Laura Barisoni; Jicheng Lv; Hong Zhang; Hai-Yan Wang; Frank C Brosius; Crystal A Gadegbeku; Matthias Kretzler
Journal:  Sci Transl Med       Date:  2015-12-02       Impact factor: 17.956

4.  Expression of epidermal growth factor and its receptor in rabbits with ischaemic acute renal failure.

Authors:  T Taira; A Yoshimura; K Iizuka; K Inui; K Oshiden; S Iwasaki; T Ideura; S Koshikawa
Journal:  Virchows Arch       Date:  1996-03       Impact factor: 4.064

5.  Decreased urinary epidermal growth factor levels in diabetic patients.

Authors:  Y Abe; M Miyake; A Horiuchi; S Kimura
Journal:  Jpn J Surg       Date:  1991-07

6.  Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children.

Authors:  Baihong Li; Yanqin Zhang; Fang Wang; Viji Nair; Fangrui Ding; Huijie Xiao; Yong Yao; Matthias Kretzler; Wenjun Ju; Jie Ding
Journal:  Pediatr Nephrol       Date:  2018-06-11       Impact factor: 3.714

7.  Urinary prostaglandin E2 is a biomarker of early adaptive hyperfiltration in solitary functioning kidney.

Authors:  Tarak Srivastava; Wenjun Ju; Ginger L Milne; Mohamed H Rezaiekhaligh; Vincent S Staggs; Uri S Alon; Ram Sharma; Jianping Zhou; Ashraf El-Meanawy; Ellen T McCarthy; Virginia J Savin; Mukut Sharma
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-12-12       Impact factor: 3.813

8.  Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.

Authors:  Bancha Satirapoj; Rattanawan Dispan; Piyanuch Radinahamed; Chagriya Kitiyakara
Journal:  BMC Nephrol       Date:  2018-09-21       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.